Literature DB >> 7607765

Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up.

G Piovaccari1, R M Ferretti, F Prati, A M Traini, M Gobbi, L Caravita, A Branzi, B Magnani.   

Abstract

Occult or overt but delayed cardiac disease after thoracic radiotherapy for Hodgkin's disease may be common. Detailed cardiac evaluation was performed in 108 patients, mean age 46 +/- 6.2 years, with Hodgkin's disease at 175 +/- 43 months after irradiation. The study protocol included clinical examination, graded treadmill exercise test and echocardiography. Some patients with angina pectoris, previous myocardial infarction and an abnormal ECG were studied by thallium-201 scintigraphy, cardiac catheterization and coronary angiography. Cardiac disease was found in 12 patients (11%). Three patients had angina pectoris, one patient had myocardial infarction, two complained of dyspnea on effort and two had congestive heart failure. At catheterization, constrictive pericarditis was diagnosed in four patients; in two additional patients an occult constrictive pericarditis was found. One patient had both mitral and tricuspidal regurgitation and one had mitral regurgitation alone. Eight patients (7.4%) had severe coronary artery disease; four of these had associated constrictive pericarditis. Four patients had a pericardiectomy and another four had undergone coronary artery by-pass graft. Two patients died after operation from persistent pericardial constriction. It is concluded that the incidence of delayed cardiac disease after radiotherapy is relatively high; chronic pericardial disorders and coronary artery disease are the most frequent manifestations of this disease. Standard surgical treatment may be beneficial because of the relative youth of these patients.

Entities:  

Mesh:

Year:  1995        PMID: 7607765     DOI: 10.1016/0167-5273(95)02276-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

2.  Cardiac surgery in patients irradiated for Hodgkin's lymphoma.

Authors:  S Siregar; F de Heer; L A van Herwerden
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

Review 3.  Constrictive Pericarditis 5 Months after Radiation Therapy in a 62-Year-Old Woman with Esophageal Cancer.

Authors:  Beeletsega T Yeneneh; Sorcha Allen; Prasad Panse; Farouk Mookadam; William Rule
Journal:  Tex Heart Inst J       Date:  2017-12-19

4.  Post-irradiation constrictive pericarditis following thymoma treatment: a report of two cases.

Authors:  Yu Hikosaka; Motoki Yano; Shinya Otsuka; Hidefumi Sasaki; Satoru Moriyama; Katsuhiro Okuda; Masayuki Shitara; Yoshitaka Fujii
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-03

5.  Impaired vascular function in asymptomatic young adult survivors of Hodgkin Lymphoma following mediastinal radiation.

Authors:  Shayna Zelcer; Breanna Chen; Joy Mangel; Olga Vujovic; Heather R Thiessen-Philbrook; Michael Reider; Farid H Mahmud
Journal:  J Cancer Surviv       Date:  2010-07-21       Impact factor: 4.442

Review 6.  Radiation-Induced Cardiovascular Toxicities.

Authors:  Shahed N Badiyan; Lindsay L Puckett; Gregory Vlacich; Walter Schiffer; Lauren N Pedersen; Joshua D Mitchell; Carmen Bergom
Journal:  Curr Treat Options Oncol       Date:  2022-09-10

7.  Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors.

Authors:  Elissa A S Polomski; Julius C Heemelaar; Augustinus D G Krol; Marloes Louwerens; Saskia L M A Beeres; Eduard R Holman; J Wouter Jukema; Martin J Schalij; M Louisa Antoni
Journal:  Cancers (Basel)       Date:  2022-05-08       Impact factor: 6.575

Review 8.  Radiation Toxicity to the Cardiovascular System.

Authors:  Konstantinos Marmagkiolis; William Finch; Despina Tsitlakidou; Tyler Josephs; Cezar Iliescu; John F Best; Eric H Yang
Journal:  Curr Oncol Rep       Date:  2016-03       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.